NCT00597467

Brief Summary

To compare the safety and efficacy of the CVI silicone-hydrogel lens worn on an extended wear basis for a period of up to 7 days and 6 nights with the Acuvue 2 soft contact lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
460

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2006

Geographic Reach
1 country

23 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2006

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2007

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 27, 2007

Completed
22 days until next milestone

First Posted

Study publicly available on registry

January 18, 2008

Completed
Last Updated

July 17, 2020

Status Verified

July 1, 2020

Enrollment Period

1.7 years

First QC Date

December 27, 2007

Last Update Submit

July 15, 2020

Conditions

Keywords

myopiahyperopiaextended wearametropia

Outcome Measures

Primary Outcomes (1)

  • Frequency of serious and significant AEs

    Frequency of serious and significant AEs defined as a composite of infiltrates of higher than grade 2 and/or infiltrates with any overlying staining, peripheral ulcer, and loss of two or more lines of visual acuity at any time during the trial

    1 Year

Secondary Outcomes (1)

  • Contact Lens Visual Acuity

    1 Year

Study Arms (2)

Test Contact Lenses

EXPERIMENTAL

VISA (comfilcon A) Silicone Hydrogel Soft contact lens

Device: VISA (comfilcon A) Silicone Hydrogel Soft contact lens

Control Contact Lenses

ACTIVE COMPARATOR

Acuvue 2 Soft Contact Lens

Device: Acuvue 2 Soft Contact Lens

Interventions

Test device

Also known as: Biofinity (comfilcon A)
Test Contact Lenses

Control device

Control Contact Lenses

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be at least 18 years of age as of the date of evaluation.
  • Require lens powers between -0.50 and -6.00 diopters sphere with no more than 1.00 diopter of refractive astigmatism and be willing to wear lenses in both eyes.
  • Be correctable to visual acuities of at least 20/25 in each eye with spectacles.
  • Be in good general health, based on his/her knowledge.
  • Be able and willing to adhere to the instructions set forth in this protocol and able to keep all specified appointments.
  • Possess wearable and visually functional eyeglasses.

You may not qualify if:

  • Previously unsuccessful with contact lens wear.
  • Rigid gas permeable contact lens wear within the past 12 months.
  • Previous refractive surgery; current or previous orthokeratology treatment.
  • Subject is wearing lenses in a modified monovision modality (multifocal lens in one eye). NOTE: subjects may not wear monovision lenses at any time during the study unless they are wearing spherical monovision lenses prior to enrollment.
  • Aphakia, keratoconus or an irregular cornea.
  • A known history of corneal hypoesthesia
  • Clinically significant (grade 3 or 4) anterior segment abnormalities or any infection of the eye, lids, or associated structures.
  • Ocular or systemic disease or need for medication which might interfere with contact lens wear. i.e., Sjögren's syndrome, type II diabetes, etc.
  • Slit lamp findings that would contraindicate contact lens wear, including but not limited to:
  • History of corneal ulcer, corneal infiltrates or fungal infections.
  • Pterygium, pinguecula or corneal scars within the visual axis
  • Pathological dry eye or associated findings (examples: Sjögren's syndrome, lupus erythematosus, sclerodermia)
  • Neovascularization or ghost vessels \> 1mm in from the limbus
  • Seborrheic eczema, seborrheic conjunctivitis
  • History of papillary conjunctivitis greater than Grade 2 (Mild)
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (23)

La Mesa Vision Care Center

La Mesa, California, 91941, United States

Location

(Private Practice)

San Diego, California, 92123, United States

Location

Drs. Cook, Reeder and Associates

San Diego, California, 92129, United States

Location

(Private Practice)

Santa Monica, California, 90403, United States

Location

Eye Care Associates, P.C.

Fort Collins, Colorado, 80521, United States

Location

Eola Eyes

Orlando, Florida, 32801, United States

Location

(Private Practice)

Honolulu, Hawaii, 96814, United States

Location

Kato & Shoji Optometrists

Honolulu, Hawaii, 96815, United States

Location

Eye Care Associates of Hawaii

Waipahu, Hawaii, 96797, United States

Location

Davis Eyecare Associates

Oak Lawn, Illinois, 60453, United States

Location

(Private Practice)

Andover, Massachusetts, 01810, United States

Location

Vision Care Associates

East Lansing, Michigan, 48823, United States

Location

The Koetting Associates Inc.

St Louis, Missouri, 63144, United States

Location

Concord Ophthalmological Associates

Concord, New Hampshire, 03301, United States

Location

Place Optical Company Inc

Le Roy, New York, 14482, United States

Location

Quinn Quinn & Associates

Athens, Ohio, 45701, United States

Location

Western Reserve Vision Care

Beachwood, Ohio, 44122, United States

Location

Ohio State University

Columbus, Ohio, 43210, United States

Location

Professional Eye Care Associates

Columbus, Ohio, 43215, United States

Location

Primary Eyecare Group, P.C.

Brentwood, Tennessee, 37027, United States

Location

(Private Practice)

Salt Lake City, Utah, 84106, United States

Location

Twin Lakes Vision

Federal Way, Washington, 98023, United States

Location

Snowy Range Vision Center

Laramie, Wyoming, 82070, United States

Location

MeSH Terms

Conditions

Refractive ErrorsMyopiaHyperopia

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

  • William Gleason, OD

    FRS

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 27, 2007

First Posted

January 18, 2008

Study Start

March 1, 2006

Primary Completion

November 1, 2007

Study Completion

November 1, 2007

Last Updated

July 17, 2020

Record last verified: 2020-07

Locations